TCL Archive Analyzing Tumor Tissue In Clinical Trials Can Improve Outcomes, RTOG Trial Finds By Cancer History Project May 27, 2011
TCL Archive Targeting One Specific Protein Can Double PFS; Triple Overall Survival By Cancer History Project May 27, 2011
TCL Archive Revlimid Maintenance Therapy Delayed Progression by 90% By Cancer History Project May 27, 2011
TCL Archive Drug Effectiveness Weakens After Three Years, Study Says By Cancer History Project May 27, 2011
TCL Archive Nexavar Improves PFS In HER-2 Negative Breast Cancer By Cancer History Project May 27, 2011
TCL Archive Xgeva Significantly Increases Bone Metastasis-Free Survival By Cancer History Project May 27, 2011
TCL Archive U.S. Patients Use More Chemotherapy, Less Emergency Care than Canadians By Cancer History Project May 27, 2011
TCL Archive Urocidin May Provide Alternative To Cystectomy in BCG Cancers By Cancer History Project May 27, 2011
Article Robert Mayer talks about the half-century of misses that preceded the development of daraxonrasib By Cancer History Project
